MedPath

Study of homology and dissimilarity between immune-related colitis and ulcerative colitis

Not Applicable
Recruiting
Conditions
immune-related colitis
Registration Number
JPRN-UMIN000036492
Lead Sponsor
Keio University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

The following patients must be excluded: 1) Patients who have severe psychiatric disease. 2) Patients who are considered to be difficult to take a colonoscopy for their condition. 3) Patients who are taking two or more antithrombotic drugs and it is difficult to withdraw them for endoscopic biopsy. 4) Patients who are suspected of infectious enterocolitis, and taking some antibiotics. 5) Patients who are judged inappropriate for entry to this clinical trial by doctors. irAE-colitis group 1) Patients who suffered colitis within 4 weeks after administration of immune checkpoint inhibitors. Ulcerative colitis group 1) Not defined.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pathological findings and endoscopic findings of immune-related colitis.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath